- Home
- NML vs TRDA Comparison
NML vs TRDA Comparison
Compare NML & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NML
- TRDA
- Stock Information
- Founded
- NML 2012
- TRDA 2016
- Country
- NML United States
- TRDA United States
- Employees
- NML N/A
- TRDA N/A
- Industry
- NML Finance/Investors Services
- TRDA Biotechnology: Pharmaceutical Preparations
- Sector
- NML Finance
- TRDA Health Care
- Exchange
- NML Nasdaq
- TRDA Nasdaq
- Market Cap
- NML 517.3M
- TRDA 548.2M
- IPO Year
- NML N/A
- TRDA 2021
- Fundamental
- Price
- NML $9.44
- TRDA $13.06
- Analyst Decision
- NML
- TRDA Strong Buy
- Analyst Count
- NML 0
- TRDA 3
- Target Price
- NML N/A
- TRDA $25.67
- AVG Volume (30 Days)
- NML 219.3K
- TRDA 128.3K
- Earning Date
- NML 01-01-0001
- TRDA 03-12-2025
- Dividend Yield
- NML 9.75%
- TRDA N/A
- EPS Growth
- NML N/A
- TRDA N/A
- EPS
- NML N/A
- TRDA 1.55
- Revenue
- NML N/A
- TRDA $215,232,000.00
- Revenue This Year
- NML N/A
- TRDA $47.45
- Revenue Next Year
- NML N/A
- TRDA N/A
- P/E Ratio
- NML N/A
- TRDA $8.18
- Revenue Growth
- NML N/A
- TRDA 146.92
- 52 Week Low
- NML $6.09
- TRDA $11.35
- 52 Week High
- NML $7.33
- TRDA $21.79
- Technical
- Relative Strength Index (RSI)
- NML 71.28
- TRDA 28.97
- Support Level
- NML $8.81
- TRDA $12.02
- Resistance Level
- NML $9.51
- TRDA $18.76
- Average True Range (ATR)
- NML 0.20
- TRDA 0.91
- MACD
- NML 0.07
- TRDA -0.41
- Stochastic Oscillator
- NML 92.42
- TRDA 15.43
About NML Neuberger Berman Energy Infrastructure and Income Fund Inc.
Neuberger Berman Energy Infrastructure & Income Fund Inc is a closed-end investment management company based in the United States.
About TRDA Entrada Therapeutics Inc.
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.